Cover Image
市場調查報告書

醫藥品原料藥 (API)的全球市場 (不同製造工程,API類別,醫藥品類別,各治療領域):產業分析,市場規模·佔有率·成長·趨勢·預測

Active Pharmaceutical Ingredients (API) Market (Manufacturing Process; API Type; Drug Type; Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023

出版商 Transparency Market Research 商品編碼 328538
出版日期 內容資訊 英文 115 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫藥品原料藥 (API)的全球市場 (不同製造工程,API類別,醫藥品類別,各治療領域):產業分析,市場規模·佔有率·成長·趨勢·預測 Active Pharmaceutical Ingredients (API) Market (Manufacturing Process; API Type; Drug Type; Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023
出版日期: 2018年04月13日 內容資訊: 英文 115 Pages
簡介

本報告提供全球醫藥品原料藥 (API) 市場相關調查,彙整市場收益的實際成果·預測,市場促進要素·阻礙要素分析,製造手法·API的種類·醫藥品的種類·治療領域及地區別的分析與預測,競爭情形,主要企業簡介等資訊,為您概述為以下內容。

第1章 序論

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • 活動的影響度分析
  • 價值鏈分析
  • 波特的五力分析
  • 市場向心力分析:各地區
  • 競爭環境:主要企業的市場規模

第4章 全球API (醫藥品原料藥) 市場:不同製造工程

  • 簡介
  • 自家製造 (公司內部生產):市場收益額 (以金額為準,總計11年份)
  • 受託製造 (外包生產):市場收益額 (以金額為準,總計11年份)

第5章 全球API市場:API類別

  • 簡介
  • 合成化學API:市場收益額 (以金額為準,總計11年份)
  • 生技藥品API:市場收益額 (以金額為準,總計11年份)

第6章 全球API市場:醫藥品類別

  • 簡介
  • 品牌處方藥API:市場收益額 (以金額為準,總計11年份)
  • 非專利處方藥API:市場收益額 (以金額為準,總計11年份)
  • 成藥 (OTC) 用API:市場收益額 (以金額為準,總計11年份)

第7章 全球API市場:各治療領域

  • 簡介
  • 心血管疾病治療藥用:市場收益額 (以金額為準,總計11年份)
  • 代謝障礙治療藥用:市場收益額 (以金額為準,總計11年份)
  • 神經病變治療藥用:市場收益額 (以金額為準,總計11年份)
  • 抗癌劑用:市場收益額 (以金額為準,總計11年份)
  • 肌肉骨骼障礙治療藥用:市場收益額 (以金額為準,總計11年份)
  • NSAID (非類固醇系抗發炎藥) 治療藥用:市場收益額 (以金額為準,總計11年份)
  • 其他的治療藥用:市場收益額 (以金額為準,總計11年份)

第8章 全球API市場:各地區

  • 簡介
  • 北美的API市場:各國 (以金額為準,總計11年份)
    • 美國,加拿大
  • 亞太地區的API市場收益額:各國 (以金額為準,總計11年份)
    • 中國,日本,印度等
  • 歐洲的API市場:各國 (以金額為準,總計11年份)
    • 德國,英國等
  • 其他的國? (RoW)

第9章 建議

  • 在標的地區透過企業收購擴張生產能力
  • 獲得特定API分子領域的成本主導權

第10章 企業簡介

  • Allergan plc
  • BASF SE
  • Boehringer Ingelheim GmbH
  • Cambrex Corporation
  • Dr. Reddy's Laboratories
  • Lonza Group
  • Mylan N.V.
  • Pfizer, Inc.
  • Sandoz (Novartis AG)
  • Teva Pharmaceutical Industries Ltd.
  • WuXi AppTec

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Title:
Active Pharmaceutical Ingredients (API) Market
(Manufacturing Process - Captive and Contract; API Type - Synthetic Chemical and Biological; Drug Type - Branded, Generic, and OTC; Therapeutic Area - Cardiovascular, Metabolic, Neurological, Oncology, Musculoskeletal, and NSAIDs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023.

Global Active Pharmaceutical ingredients Market: Overview

Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. APIs of good quality are essential for the manufacture of effective and safe medicines. However, not all pharmaceutical companies possess in-house API manufacturing capabilities. Furthermore, a single company cannot produce all the APIs required for their formulation offerings.

The report provides detailed qualitative analysis of the market dynamics that affect the growth of the global market. Factors responsible for driving and restraining the growth of the global API market and future opportunities has been provided in the market overview section. This section of the report also provides comprehensive market comparative analysis and market attractiveness analysis for the global market by geography for the base year, Porter's Five Forces analysis, and market share analysis by key players (%) for the base year, operating in the active pharmaceutical ingredients market. The report also encompasses detailed event impact analysis and value chain analysis for the global market.

Global Active Pharmaceutical ingredients Market: Segmentations

The global market has been broadly segmented on the basis of manufacturing process, type of API, types of drugs, therapeutic areas and geography. This report analyzes the current scenario as well as future market potential for market globally. This report comprises an elaborate executive summary, demonstrating a snapshot on market dynamics of various segments and sub-segments in a precise manner. Moreover, executive summary also comprises a waterfall chart, which reflects the market size of various segments in descending order.

The global API market is categorized in to captive manufacturing and contract manufacturing. Types of active pharmaceutical ingredients described in the global market include synthetic chemical API and biological API. Branded prescription drugs, generic prescription drugs, and over-the-counter drugs are various types of drugs covered in the global market. The global market encompasses various therapeutic areas such as cardiovascular disorders, oncology, metabolic disorders, neurological disorders, musculoskeletal disorders, NSAIDs and other therapeutic uses (such as infectious diseases). The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers.

Global Active Pharmaceutical ingredients Market: Regional Analysis

Geographies discussed and analyzed in the global market include North America, Europe, Asia Pacific, and Rest of the World. In addition the report also comprises the precise and detailed country wise analysis for the global active pharmaceutical ingredients market such as North America (U.S. and Canada), Asia Pacific (China, Japan, India and Rest of Asia Pacific), and Europe (Germany, U.K. and Rest of Europe). The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2013 to 2023. The report on the market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2017 to 2023, considering 2016 as the base year.

Global Active Pharmaceutical ingredients Market: Competitive Landscape

A list of recommendations have been provided for new entrants to help establish a strong presence and for existing market players to take strategic decisions and to increase their market shares in the global active pharmaceutical ingredient market. The report concludes with the profiles of major players in the market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Allergan plc, BASF SE, Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy's Laboratories Ltd., Lonza Group, Mylan, Inc., Sandoz (Novartis AG), Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and WuXi Apptec.

Key Segments of the Global Active Pharmaceutical Ingredients Market:

By Manufacturing Process

  • Captive Manufacturing
  • Contract Manufacturing

By API Type

  • Synthetic Chemical API
  • Biological API

By Drug Type

  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Prescription Drugs

By Therapeutic Area

  • Cardiovascular Disorders
  • Metabolic Disorders
  • Neurological Disorders
  • Oncology
  • Musculoskeletal Disorders
  • NSAIDs
  • Other Therapeutics Uses

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1: Preface

Chapter 2: Executive Summary

  • 2.1. Introduction
  • 2.2. Global Market: Market Snapshot
  • 2.3. Comparative Analysis: Global Active Pharmaceutical Ingredients Market, by Geography(2015 & 2023)
  • 2.4. Waterfall Diagram: Global API Market Revenue, by Therapeutic Area, 2015(US$ Mn)

Chapter 3: Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. Increase in healthcare expenditure to drive market growth
      • 3.2.1.2. Rapidly aging of global population expected to aid growth of the API market
      • 3.2.1.3. Increase in Abbreviated New Drug Applications(ANDA) in the recent past to boost the demand for APIs
    • 3.2.2. Restraint
      • 3.2.2.1. Adverse regulatory policies to be an important restraining factor
    • 3.2.3. Opportunity
      • 3.2.3.1. Patent Expiry of Major Biological Drugs in the U.S. and EU
      • 3.2.3.2. Growth of the healthcare market in Asia-Pacific and rest of the world(RoW) segments
  • 3.3. Event Impact Analysis
  • 3.4. Value Chain Analysis
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis: Global Market, by Geography, 2015
  • 3.7. Competitive Landscape: Global Market, by Key Players, 2015(USD Million)

Chapter 4: By Manufacturing Process

  • 4.1. Introduction
  • 4.2. Captive Manufacturing Market Revenue, 2013-2023(US$ Mn)
  • 4.3. Contract Manufacturing Market Revenue, 2013-2023(US$ Mn)

Chapter 5: By API Type

  • 5.1. Introduction
  • 5.2. Synthetic Chemical Market Revenue, 2013-2023(US$ Mn)
  • 5.3. API Biological API Market Revenue, 2013-2023(US$ Mn)

Chapter 6: By Drug Type

  • 6.1. Introduction
  • 6.2. API Market Revenue for Branded Prescription Drugs, 2013-2023(US$ Mn)
  • 6.3. API Market Revenue for Generic Prescription Drugs, 2013-2023(US$ Mn)
  • 6.4. API Market Revenue for OTC Prescription Drugs, 2013-2023(US$ Mn)

Chapter 7: By Therapeutic Area

  • 7.1. Introduction
  • 7.2. API Market Revenue for Cardiovascular Disorders Drug, 2013-2023(US$ Mn)
  • 7.3. API Market for Drugs for Metabolic Disorders, 2013-2023(US$ Mn)
  • 7.4. API Market for Drugs for Neurological Disorders, 2013-2023(US$ Mn)
  • 7.5. API Market for Drugs for Oncology, 2013-2023(US$ Mn)
  • 7.6. API Market for Drugs for Musculoskeletal Disorders, 2013-2023(US$ Mn)
  • 7.7. API Market for NSAIDs, 2013-2023(US$ Mn)
  • 7.8. API Market for Drugs for Other Therapeutics Uses, 2013-2023(US$ Mn)

Chapter 8: By Region

  • 8.1. Introduction
  • 8.2. North America API Market Revenue, by Country, 2013-2023(US$ Mn)
    • 8.2.1. U.S. API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.2.2. Canada API Market Revenue, 2013-2023,(US$ Mn)
  • 8.3. Asia-Pacific Market Revenue, by Country, 2013-2023(US$ Mn)
    • 8.3.1. China API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.3.2. Japan API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.3.3. India API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.3.4. Rest of Asia-Pacific API Market Revenue,, 2013-2023,(US$ Mn)
  • 8.4. Europe
    • 8.4.1. Germany API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.4.2. U.K. API Market Revenue,, 2013-2023,(US$ Mn)
    • 8.4.3. Rest of Europe API Market Revenue,, 2013-2023,(US$ Mn)
  • 8.5. Rest of the World

Chapter 9: Recommendations

  • 9.1. Enhance manufacturing capacity through acquisitions in targeted geographies
  • 9.2. Achieve cost leadership in specific API molecules

Chapter 10: Company Profiles

  • 10.1. Allergan plc
  • 10.2. BASF SE
  • 10.3. Boehringer Ingelheim GmbH
  • 10.4. Cambrex Corporation
  • 10.5. Dr. Reddy's Laboratories
  • 10.6. Lonza Group
  • 10.7. Mylan N.V.
  • 10.8. Pfizer, Inc.
  • 10.9. Sandoz(Novartis AG)
  • 10.10. Teva Pharmaceutical Industries Ltd.
  • 10.11. WuXi AppTec
Back to Top